Peptidoglycan Complex of Spirulina K-001 clinical trials
How each study uses Peptidoglycan Complex of Spirulina K-001 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- K-001
- 3
Studies by the year they started
3 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 2
Kowa Research Institute, Inc. (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1) · RenJi Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Peptidoglycan Complex of Spirulina K-001 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452CompletedPhase 1Kowa Research Institute, Inc.NCT05722262Written as K-001How we know
- The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic CancerStatus unknownPhase 2/3RenJi HospitalNCT04183478Written as K-001How we know
- K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's TolerabilityCompletedPhase 1Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineNCT02720666Written as K-001How we know